SEATTLE--(BUSINESS WIRE)--LifeSpan BioSciences, Inc. (LSBio), a leading provider of antibodies to researchers worldwide, today announced exclusive distribution agreements with select strategic partners making the full LSBio catalog of 75,000 antibodies, including 3,600 IHC-validated, IHC-plus™ antibodies, available around the globe. LSBio expects to improve international customer support by providing researchers worldwide with local access to the Company’s vast catalog of high quality, well characterized and diverse reagents and antibodies.
